武田薬品工業の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2010/06/08 | 3,760 | 3,790 | 3,745 | 3,775 | +25 | +0.7% | 1,810,700 |
| 2010/06/07 | 3,765 | 3,780 | 3,740 | 3,750 | -85 | -2.2% | 2,599,500 |
| 2010/06/04 | 3,835 | 3,860 | 3,820 | 3,835 | -35 | -0.9% | 1,842,400 |
| 2010/06/03 | 3,830 | 3,880 | 3,820 | 3,870 | +85 | +2.2% | 2,524,200 |
| 2010/06/02 | 3,785 | 3,820 | 3,775 | 3,785 | -20 | -0.5% | 2,504,000 |
| 2010/06/01 | 3,825 | 3,825 | 3,755 | 3,805 | +10 | +0.3% | 2,358,200 |
| 2010/05/31 | 3,750 | 3,820 | 3,735 | 3,795 | +45 | +1.2% | 2,725,700 |
| 2010/05/28 | 3,740 | 3,775 | 3,705 | 3,750 | +30 | +0.8% | 3,308,300 |
| 2010/05/27 | 3,710 | 3,730 | 3,690 | 3,720 | -5 | -0.1% | 3,204,900 |
| 2010/05/26 | 3,705 | 3,785 | 3,705 | 3,725 | +5 | +0.1% | 4,333,300 |
| 2010/05/25 | 3,730 | 3,750 | 3,710 | 3,720 | -35 | -0.9% | 2,899,700 |
| 2010/05/24 | 3,715 | 3,800 | 3,710 | 3,755 | +15 | +0.4% | 3,253,300 |
| 2010/05/21 | 3,800 | 3,800 | 3,730 | 3,740 | -115 | -3% | 3,731,900 |
| 2010/05/20 | 3,870 | 3,875 | 3,850 | 3,855 | -25 | -0.6% | 1,960,200 |
| 2010/05/19 | 3,855 | 3,895 | 3,850 | 3,880 | -20 | -0.5% | 2,417,300 |
| 2010/05/18 | 3,905 | 3,925 | 3,880 | 3,900 | +30 | +0.8% | 2,067,900 |
| 2010/05/17 | 3,860 | 3,890 | 3,850 | 3,870 | -45 | -1.1% | 3,325,000 |
| 2010/05/14 | 3,900 | 3,945 | 3,870 | 3,915 | -35 | -0.9% | 3,607,800 |
| 2010/05/13 | 3,950 | 3,955 | 3,850 | 3,950 | -40 | -1% | 4,173,700 |
| 2010/05/12 | 3,990 | 4,010 | 3,955 | 3,990 | +10 | +0.3% | 2,278,600 |
| 2010/05/11 | 3,980 | 4,000 | 3,960 | 3,980 | +70 | +1.8% | 3,669,600 |
| 2010/05/10 | 3,855 | 3,925 | 3,850 | 3,910 | +5 | +0.1% | 3,422,800 |
| 2010/05/07 | 3,915 | 3,960 | 3,900 | 3,905 | -95 | -2.4% | 3,978,800 |
| 2010/05/06 | 4,000 | 4,050 | 3,985 | 4,000 | -50 | -1.2% | 4,588,300 |
| 2010/04/30 | 4,000 | 4,090 | 4,000 | 4,050 | +130 | +3.3% | 5,273,600 |
| 2010/04/28 | 3,940 | 3,945 | 3,920 | 3,920 | -80 | -2% | 2,906,200 |
| 2010/04/27 | 4,000 | 4,010 | 3,960 | 4,000 | ±0 | ±0% | 2,108,300 |
| 2010/04/26 | 3,995 | 4,030 | 3,990 | 4,000 | +30 | +0.8% | 2,609,000 |
| 2010/04/23 | 4,010 | 4,015 | 3,950 | 3,970 | -40 | -1% | 3,454,600 |
| 2010/04/22 | 4,030 | 4,035 | 4,005 | 4,010 | -70 | -1.7% | 2,234,000 |
| 2010/04/21 | 4,095 | 4,105 | 4,070 | 4,080 | +25 | +0.6% | 2,149,900 |
| 2010/04/20 | 4,070 | 4,100 | 4,050 | 4,055 | +5 | +0.1% | 1,935,600 |
| 2010/04/19 | 4,105 | 4,120 | 4,050 | 4,050 | -85 | -2.1% | 2,135,300 |
| 2010/04/16 | 4,140 | 4,150 | 4,120 | 4,135 | -5 | -0.1% | 2,374,800 |
| 2010/04/15 | 4,180 | 4,185 | 4,135 | 4,140 | -5 | -0.1% | 1,891,500 |
| 2010/04/14 | 4,180 | 4,200 | 4,135 | 4,145 | -20 | -0.5% | 1,986,100 |
| 2010/04/13 | 4,185 | 4,185 | 4,150 | 4,165 | -15 | -0.4% | 1,773,200 |
| 2010/04/12 | 4,165 | 4,180 | 4,160 | 4,180 | +40 | +1% | 2,467,900 |
| 2010/04/09 | 4,135 | 4,155 | 4,130 | 4,140 | +10 | +0.2% | 3,100,500 |
| 2010/04/08 | 4,140 | 4,160 | 4,125 | 4,130 | -20 | -0.5% | 1,492,700 |
| 2010/04/07 | 4,155 | 4,170 | 4,140 | 4,150 | +15 | +0.4% | 2,517,200 |
| 2010/04/06 | 4,095 | 4,135 | 4,090 | 4,135 | +55 | +1.3% | 2,357,100 |
| 2010/04/05 | 4,125 | 4,135 | 4,070 | 4,080 | -30 | -0.7% | 2,144,400 |
| 2010/04/02 | 4,170 | 4,170 | 4,105 | 4,110 | -40 | -1% | 2,288,600 |
| 2010/04/01 | 4,140 | 4,160 | 4,115 | 4,150 | - | - | 2,736,400 |
3701～
3745
件表示中 / 3745件
類似銘柄と比較する
現在ご覧いただいている「武 田」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 武 田 | 434,100円 | -1.1% | +75.3% | 4.61% | 30.06倍 | 0.99倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位１０強入り |
| 中外薬 | 700,400円 | +1.7% | +5.0% | 3.57% | 28.11倍 | 6.06倍 |
|
ロシュ傘下で成長続ける異色の医薬品大手。抗体・バイオで先行、抗がん剤、骨・関節領域に強い |
| 第一三共 | 359,800円 | +6.0% | +4.0% | 2.17% | 22.34倍 | 4.13倍 |
|
国内製薬大手。循環器と感染症薬強い。英アストラゼネカ社と提携し、がん領域の開拓中 |
| 大塚ＨＤ | 658,100円 | +2.2% | +10.2% | 1.82% | 12.64倍 | 1.27倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界９０カ所に工場 |
| アステラス薬 | 144,800円 | +0.9% | +380.2% | 5.39% | 19.94倍 | 1.71倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
市場注目の銘柄
チャート関連のコラム
